Welcome to our dedicated page for Arcadia Biosciences news (Ticker: RKDA), a resource for investors and traders seeking the latest updates and insights on Arcadia Biosciences stock.
Arcadia Biosciences, Inc. (NASDAQ: RKDA) is a pioneering company in the field of agricultural biotechnology, focused on developing and marketing high-value food ingredients and nutritional oils. The company’s mission is to meet the growing consumer demand for healthier dietary options through its innovative product offerings.
Among Arcadia’s standout products are its GoodWheat™ branded ingredients, which provide significant health benefits and allow consumer packaged goods companies to differentiate their brands in a competitive marketplace. Additionally, Arcadia is committed to enhancing agricultural productivity and sustainability through its portfolio of agricultural traits. These traits are designed to help farmers around the world increase crop yields and reduce the environmental impact of farming practices.
The company is engaged in science-based approaches to crop improvement, with a focus on wheat, soy, and hemp. These efforts aim not only to improve the performance of these crops in the field but also to enhance their value in food, health, and wellness products, as well as their industrial applications.
Arcadia’s consumer brands cater to a range of markets, including food, beverage, and body care. Some notable brands include GoodWheat™ high-fiber pasta and Zola coconut water. These products highlight the company’s dedication to providing nutritious and beneficial options to consumers.
Recent achievements and ongoing projects reflect Arcadia’s commitment to innovation and sustainability. By leveraging advanced agricultural biotechnology, the company continues to contribute to a healthier future while supporting global agricultural productivity.
For more detailed information and the latest updates, visit their official website at www.arcadiabio.com.
Arcadia Biosciences, Inc. (NASDAQ: RKDA) has been granted a new patent by the U.S. Patent and Trademark Office for its high fiber resistant starch GoodWheat™, expanding its intellectual property in genome editing. This patent is the 28th for GoodWheat, which offers significant health benefits like eight times the dietary fiber and 30% fewer calories than conventional wheat. Arcadia recently launched premium GoodWheat pasta and flour products through partnerships, enhancing its market presence in North America.
Arcadia Biosciences (Nasdaq: RKDA) announced its participation in the H.C. Wainwright Global Life Sciences Conference scheduled for March 9-10, 2021. The company aims to showcase its innovative approaches to enhancing crop quality and nutritional value through scientific methods. President and CEO Matt Plavan will provide an overview of the business and engage in one-on-one meetings with investors. The presentation will be available on-demand starting March 9 at 7:00 AM (EST) and will include a replay accessible via the company’s website.
Arcadia Biosciences (Nasdaq: RKDA) announced the appointment of Debbie Carosella to its board of directors. Carosella, former CEO of Madhava Natural Sweeteners, brings extensive experience in the food industry, having held leadership roles at Dean Foods and ConAgra Foods. Her expertise in consumer marketing and brand development is expected to enhance Arcadia's commercial strategy for its health-focused products, GoodWheat™ and GoodHemp™. CEO Kevin Comcowich expressed confidence in her ability to drive innovation and growth for the company's product lines.
Arcadia Biosciences (Nasdaq: RKDA) announced that its GoodHemp™ seed varieties – Rogue, Umpqua, Santiam, and Potomac – have achieved certification from the Association of Official Seed Certifying Agencies (AOSCA). This certification ensures quality assurance and varietal purity, crucial for growers in the hemp industry. AOSCA-certified seeds are eligible for certified hemp seed production, meeting stringent U.S. Seed Act standards. The varieties are designed to enhance yield and are available for planting in states like Florida, boosting the company's position in the hemp market.
On January 25, 2021, Arcadia Biosciences (Nasdaq: RKDA) announced a private placement, raising approximately $25.1 million by selling 7,876,784 shares at $3.1925 per share. The company will also issue warrants for up to 3,938,392 shares at an exercise price of $3.13. The funds will be allocated towards general corporate purposes, including the expansion of the GoodWheat™ brand and e-commerce initiatives. The offering is expected to close on or about January 27, 2021.
Arcadia Biosciences (Nasdaq: RKDA) has successfully closed a registered direct offering of 2,618,658 shares, priced at $2.93 per share, yielding approximately $7.7 million in gross proceeds. In a concurrent private placement, the company issued warrants for an additional 2,618,658 shares at $0.125 each, generating about $327,000. The net proceeds, estimated at $7.3 million, will primarily fund customer acquisition for GoodWheat and related marketing initiatives, supporting revenue growth strategies into 2021 amid potential economic volatility.
Arcadia Biosciences (Nasdaq: RKDA) announced a registered direct offering of 2,618,658 shares at a price of $3.055 per share, aiming to raise approximately $8 million in gross proceeds. The offering includes warrants to purchase an equal number of shares at an exercise price of $3.00, exercisable immediately and expiring in five and a half years. The funds will support customer acquisition for GoodWheat, digital marketing, and corporate costs. The closing is expected around December 22, 2020.
Arcadia Biosciences (Nasdaq: RKDA) announced a distribution agreement with Tritium 3H, Inc. for its GoodHemp seed varieties in Canada. The agreement follows extensive field tests and will see the initial distribution of three CBD dominant varieties: Umpqua, Rogue, and Santiam. AOSCA certification is expected in mid-December, with Health Canada certification anticipated in February. CEO Matt Plavan emphasized the commercialization acceleration of Arcadia's hemp genetics, while Tritium CEO Jayme Hunter praised the performance of the seeds in Canadian trials.
Arcadia Biosciences, Inc. (Nasdaq: RKDA) announced third-quarter 2020 results, reporting revenues of $314,000, down 20% from $392,000 in Q3 2019. Operating expenses increased to $7.9 million, while the net loss attributable to common shareholders decreased to $6.4 million, or ($0.60) per share, reflecting a $7.8 million drop compared to the previous year. Key strategic transactions with Bioceres Crop Solutions will enhance commercialization efforts of HB4 soybeans and GoodWheat products. The company received $6 million in cash and equity from these deals.
Arcadia Biosciences (Nasdaq: RKDA) and Three Farm Daughters have launched new food products using Arcadia's non-GMO GoodWheat™ ingredients. The initial offerings include Artisan Linguine, Fusilli, Fettuccine Pasta, and 100% Wheat Flour, available online from November 12 and in select North Dakota and Minnesota stores. GoodWheat™ boasts up to nine times the fiber of traditional wheat and lower gluten and calorie content. This partnership addresses a fiber deficiency in American diets, aiming to provide consumers with healthier family food staples.
FAQ
What is the current stock price of Arcadia Biosciences (RKDA)?
What is the market cap of Arcadia Biosciences (RKDA)?
What does Arcadia Biosciences, Inc. specialize in?
What are some of Arcadia’s notable product brands?
How does Arcadia Biosciences contribute to agricultural sustainability?
What crops does Arcadia Biosciences focus on?
How does Arcadia Biosciences enhance the value of crops?
Where can I find more information about Arcadia Biosciences?
What recent achievements has Arcadia Biosciences made?
How does Arcadia Biosciences help consumer packaged goods companies?
What is the mission of Arcadia Biosciences?
What sectors does Arcadia Biosciences operate in?
